<DOC>
	<DOCNO>NCT01379300</DOCNO>
	<brief_summary>This study investigate biomarkers single oral dos anticoagulant agent dabigatran etexilate rivaroxaban healthy young male subject healthy elderly subject .</brief_summary>
	<brief_title>A Study Investigate Biomarkers After Single Doses Anticoagulants Healthy Young Male Healthy Elderly Participants ( MK-0000-216 AM1 )</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Inclusion criterion nonhemophilia participant : Panel A Male female 65 85 year age Panel B Male 18 45 year age Both Panels Weight ≥50 kg ≤110 kg In good health No clinically significant abnormality electrocardiogram ( ECG ) Nonsmoker and/or use nicotine nicotinecontaining product least approximately 6 month Exclusion criterion nonhemophilia participant : History stroke , chronic seizure , major neurological disorder History clinically significant endocrine , gastrointestinal ( include peptic ulcer disease ) , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality diseases History malignant neoplastic disease , exception adequately treat nonmelanomatous skin carcinoma malignancy successfully treat ≥10 year prior study History thrombotic plateletrelated disorder include prior deep venous thrombosis pulmonary embolus Use warfarin , coumadin , heparin , aspirin , dabigatran etexilate , rivaroxaban dipyridamole within 2 week History poor wind heal Unable refrain anticipates use medication , include aspirin aspirincontaining product , nonsteroidal antiinflammatory drug ( NSAID ) containing product ( include pain , cold allergy product , etc . ) include prescription nonprescription drug herbal remedy ( St. John 's Wort [ Hypericum perforatum ] ) begin approximately 2 week ( 5 halflives ) prior initiation treatment period , throughout study poststudy visit Consumption excessive amount alcohol , define great 3 glass alcoholic beverage ( 1 glass approximately equivalent : beer [ 284 mL/10 ounce ] , wine [ 125 mL/4 ounce ] , distilled spirit [ 25 mL/1 ounce ] ) per day Consumption excessive amount , define great 6 serving ( 1 serve approximately equivalent 120 mg caffeine ) coffee , tea , cola , caffeinated beverage per day Major surgery , donation loss 1 unit blood ( approximately 500 mL ) participation another investigational study within 4 week History significant multiple and/or severe allergy ( include latex allergy ) , anaphylactic reaction significant intolerability prescription nonprescription drug food , include dabigatran etexilate rivaroxaban Current regular user ( include illicit drug history drug [ include alcohol ] abuse within approximately 6 month History ( include family history hereditary ) symptoms clinically relevant bleed disorder Organic lesion risk bleeding ( e.g. , aneurysm , cavernous hemangioma , arteriovenous malformation ) History frequent epistaxis recurrent active gingivitis hemorrhoid Inclusion criterion hemophilia participant : Male diagnosis hemophilia B 18 64 year age Weight ≥110 lb ≤300 lb Has receive clot factor 7 day prior blood sample No active bleed event No procedure surgery past 8 week Judged good health base medical history Has smoke 2 cigarette per day least approximately 1 week prior ; smoke pipe cigar chew tobacco least 3 day prior Can refrain use NSAIDs ( e.g. , Advil , Aleve , aspirin ) , NSAIDcontaining product ( include pain , cold , allergy product , etc . ) , herbal med drug 7 day prior date study procedure Exclusion criterion hemophilia participant : Clinically significant endocrine , gastrointestinal ( include peptic ulcer disease ) , cardiovascular , hematological ( except factor IX deficiency ) , immunological , renal , respiratory , neurological genitourinary abnormality diseases History malignant neoplastic disease , exception adequately treat nonmelanomatous skin carcinoma malignancy successfully treat ≥10 year prior study Consumption excessive amount alcohol , define great 3 glass alcoholic beverage ( 1 glass approximately equivalent : beer [ 284 mL/10 ounce ] , wine [ 125 mL/4 ounce ] , distilled spirit [ 25 mL/1 ounce ] ) within 24 hour prior study procedure Major surgery , donation loss 1 unit blood ( approximately 500 mL ) participation another investigational study within 7 day prior date study procedure Current regular user ( include illicit drug history drug [ include alcohol ] abuse within approximately 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Hemophilia B</keyword>
</DOC>